Skip to content
JournalsWorldThe Global Research Discovery Platform
SCHOLARLY PUBLICATION

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen David Silberstein, Paul K Winner, Dean K. Leonardi, Daniel D. Mikol, Robert A. Lenz

📖 The Lancet Neurology 📅 2017-04-28 🔗 DOI: 10.1016/s1474-4422(17)30083-2

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.